The influence of SLCO1B1 (OATP1B1) gene polymorphisms on response to statin therapy.
about
Lost in Translation (LiT): IUPHAR Review 6Overcoming Challenges With Statin TherapyRole of OATP-1B1 and/or OATP-1B3 in hepatic disposition of tyrosine kinase inhibitorsFlavopiridol pharmacogenetics: clinical and functional evidence for the role of SLCO1B1/OATP1B1 in flavopiridol dispositionStatin use and hip fractures in U.S. kidney transplant recipients.Safety of statins: an updateOrganic anion-transporting polypeptide 1b2 (Oatp1b2) is important for the hepatic uptake of unconjugated bile acids: Studies in Oatp1b2-null mice.Creatine kinase elevation caused by a combination of fluvastatin and telmisartan in a patient heterozygous for the CYP2C9*3 and ABCC2 -24C > T variants: a case report.Lack of pharmacokinetic interactions between pitavastatin and efavirenz or darunavir/ritonavir.Marked differences in frequencies of statin therapy relevant SLCO1B1 variants and haplotypes between Roma and Hungarian populations.Drug Transporters and Na+/H+ Exchange Regulatory Factor PSD-95/Drosophila Discs Large/ZO-1 ProteinsA pharmacogenetic pilot study reveals MTHFR, DRD3, and MDR1 polymorphisms as biomarker candidates for slow atorvastatin metabolizers.Pharmacogenomic testing: relevance in medical practice: why drugs work in some patients but not in others.The farnesoid X receptor -1G>T polymorphism influences the lipid response to rosuvastatin.Inhibition of the organic anion-transporting polypeptide 1B1 by quercetin: an in vitro and in vivo assessment.SLCO1B1 c.388A>G Polymorphism Is Associated with HDL-C Levels in Response to Atorvastatin in Chilean Individuals.Organic anion transporting polypeptides OATP1B1 and OATP1B3 and their genetic variants influence the pharmacokinetics and pharmacodynamics of raloxifeneGenetic determinants of mycophenolate-related anemia and leukopenia after transplantation.Pharmacogenomics of high-density lipoprotein-cholesterol-raising therapies.Genetic variations of bile salt transporters as predisposing factors for drug-induced cholestasis, intrahepatic cholestasis of pregnancy and therapeutic response of viral hepatitis.Pharmacogenomics and adverse drug reactions: the case of statins.Chronic obstructive pulmonary disease: patho-physiology, current methods of treatment and the potential for simvastatin in disease management.Pharmacogenetics of drug transporters in the enterohepatic circulation.Statin dose in Asians: is pharmacogenetics relevant?Pharmacogenetics of statins: achievements, whole-genome analyses and future perspectives.Review of the cost effectiveness of pharmacogenetic-guided treatment of hypercholesterolaemia.Drug-drug interactions between HMG-CoA reductase inhibitors (statins) and antiviral protease inhibitors.Pharmacogenomics of lipid-lowering therapies.Lipid-lowing pharmacogenomics in Chinese patients.Evaluation of the pharmacokinetics and drug interactions of the two recently developed statins, rosuvastatin and pitavastatin.Genetics and personalized medicine--a role in statin therapy?A Review of New Pharmacologic Treatments for Patients With Chronic Heart Failure With Reduced Ejection Fraction.Pharmacogenetic considerations in the treatment of HIV.Rhabdomyolysis After Coadministration of Atorvastatin and Sacubitril/Valsartan (Entresto™) in a 63-Year-Old Woman.Development of a broad-based ADME panel for use in pharmacogenomic studies.The effects of a single nucleotide polymorphism in SLCO1B1 on the pharmacodynamics of pravastatin.SLCO1A2, SLCO1B1 and SLCO2B1 polymorphisms influences chloroquine and primaquine treatment in Plasmodium vivax malaria.Comparison of the pharmacokinetics of pitavastatin by formulation and ethnic group: an open-label, single-dose, two-way crossover pharmacokinetic study in healthy Caucasian and Japanese men.Genetic variation in the UGT1A locus is associated with simvastatin efficacy in a clinical practice setting.Gilbert syndrome redefined: a complex genetic haplotype influences the regulation of glucuronidation.
P2860
Q24289150-8FF8D4B9-B4B9-4B7E-925F-28BAA0DBAD8AQ28073319-E2828C3A-468A-4CC2-A269-46F641F15089Q28236180-73B5E407-6C19-4ABC-BEF6-40EFD96A901AQ28475976-FDE60C3B-7025-4036-9748-B964DBD54EF5Q33623526-F314872F-6695-417E-B1B3-C2F7088C7730Q33949312-18328447-3D25-4DD6-89B0-E338A65D5026Q35264245-47B50B47-734C-45FD-A638-7D4C77B36A71Q35300044-502C839D-F025-4FEE-990B-D7A1E28E4E23Q35501523-0D154D7A-337A-4C21-B493-8765F1EF33ADQ35763066-AE93A939-1B66-463B-9E3B-08ED8EBA7AD6Q35795744-01EC188D-B97F-4DCD-BA04-57AF818AC61AQ35917726-728A4E66-4698-4A1F-92BE-A76F56724164Q35955515-1E36540C-02AD-4660-AA51-8DB505DCA363Q36020304-25AED058-44C2-4FFE-BB12-87126A56E1C0Q36111214-DE441AAA-9BFB-4A53-A186-6624D008DB4EQ36184009-D8DEDEC0-931D-4A5D-B745-43F2D48C612EQ36334805-3758499B-AB8C-4559-88F4-6054C4947FD6Q37013588-6D36B34E-6DB2-42AE-BF5B-C5874021DEC2Q37695401-1668F0FB-4802-443E-9927-ABAEFD2387FAQ37841614-A0B7389A-A67E-4897-AC60-0969BB08FC1AQ37875115-89E393D1-6457-49CD-B2A3-AA30325FF542Q37880077-F8775D8F-CC13-445C-B0C4-323EED4C9C5EQ37880875-F778E9F7-0543-4815-9260-92BE09DEB1F5Q37951651-39039856-F9D9-4CAC-85EA-54F05363E7CEQ38010751-C785D292-D708-4DC5-9014-3B6D6B9D0502Q38097339-5D75B11E-92EB-40A5-9C3E-EA404E78F9EAQ38109095-F5BAAE5B-3984-4DC8-9399-C6C24D12FCE9Q38112823-4DE6E521-045A-4598-85D3-11141A450B56Q38129422-9E26A9E6-4BC1-4B8C-A3B3-9CCAC5BF568FQ38155218-45550BB2-8193-4B21-A135-339AC27B627CQ38167710-012B79D7-0577-4B9E-80F7-12BBB9F936C9Q38655266-A55AB5B0-0314-4EC7-B1CF-F7E0B3BBB6A7Q38782609-0CBCD4F1-201F-4C8B-B441-CFE17AF88AAAQ38996413-1187A661-4169-4BEA-8CB7-5EFF15909F24Q39142325-6949A555-88BE-420C-9B29-EB0EF47367E3Q40768577-9C1205EB-E21A-41F1-A8E1-E8123D44364DQ41911842-235EC425-FEDA-4825-9CFF-759BA4DB37CDQ42614556-D5945E99-FB72-47DF-A1CF-BF4D672FE8A7Q42714050-3D297ECC-7FB6-4C81-BCD0-E48E897CB670Q42722612-2E81C526-12A7-40DA-A233-D0B7D7D22CE7
P2860
The influence of SLCO1B1 (OATP1B1) gene polymorphisms on response to statin therapy.
description
2009 nî lūn-bûn
@nan
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
name
The influence of SLCO1B1 (OATP1B1) gene polymorphisms on response to statin therapy.
@ast
The influence of SLCO1B1 (OATP1B1) gene polymorphisms on response to statin therapy.
@en
The influence of SLCO1B1
@nl
type
label
The influence of SLCO1B1 (OATP1B1) gene polymorphisms on response to statin therapy.
@ast
The influence of SLCO1B1 (OATP1B1) gene polymorphisms on response to statin therapy.
@en
The influence of SLCO1B1
@nl
prefLabel
The influence of SLCO1B1 (OATP1B1) gene polymorphisms on response to statin therapy.
@ast
The influence of SLCO1B1 (OATP1B1) gene polymorphisms on response to statin therapy.
@en
The influence of SLCO1B1
@nl
P2093
P2860
P356
P1476
The influence of SLCO1B1 (OATP1B1) gene polymorphisms on response to statin therapy
@en
P2093
A J Balmforth
K M Bailey
S P R Romaine
P2860
P2888
P356
10.1038/TPJ.2009.54
P577
2009-11-03T00:00:00Z
P6179
1018147039